SCHEMBL13637635

SCHEMBL13637635

O=C(CN1C(=O)/C(=N/O)c2ccc(Br)cc21)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
ALDH2 P05091 2/20 0.39
ALDH3A1 P30838 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
MAPK1 P28482 1/20 0.38
CTRB1 P17538 1/20 0.38
GLA P06280 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CUL4A Q13619 1/20 0.36
CDC25B P30305 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628082 0.91 ALDH1A1 (0.46) ALDH1A1ALDH2ALDH3A1L3MBTL1MAPK1
SCHEMBL17830711 0.80 ALDH1A1 (0.63) ALDH1A1ALDH2ALDH3A1CTRB1CUL4A
SCHEMBL13910806 0.80 ALDH1A1 (0.46) ALDH1A1ALDH2ALDH3A1CTRB1CUL4A
SCHEMBL6316296 0.75 ALDH1A1 (0.56) ALDH1A1MAPK1RXFP1CYP1A2CYP2C9
SCHEMBL6316299 0.75 ALDH1A1 (0.56) ALDH1A1MAPK1RXFP1CYP1A2CYP2C9
SCHEMBL14876483 0.73 CTRB1 (0.49) ALDH1A1ALDH2ALDH3A1L3MBTL1MAPK1
SCHEMBL6317939 0.72 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL6317943 0.72 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL13627900 0.72 ALDH1A1 (0.69) ALDH1A1ALDH2ALDH3A1MAPTCA12
SCHEMBL20083679 0.71 ALDH1A1 (0.63) ALDH1A1L3MBTL1MAPK1CTRB1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612065-B2 Inhibitors of c-JUN N-terminal kinases (JNK) VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-11-03 US disclosed
US-20080033022-A1 Inhibitors of c-Jun N-terminal kinases (JNK) SALITURO FRANCESCO G 2008-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080033022-A1 Inhibitors of c-Jun N-terminal kinases (JNK) MAP3K1, JUN, MAP3K7 ALDH1A1 4310/4885ALDH2 3451/4885ALDH3A1 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.